Robert Ticktin, General Counsel and COO of PMV Pharmaceuticals ($PMVP), made one open market sale of shares in the last year, totaling about $25,000. His most recent sale occurred on July 1, 2025. Among 11,678 insiders with sales, his activity ranks 10,931st by amount, well below the average of $8.6 million across about 6 transactions per insider. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | PMV Pharmaceuticals, Inc. | $PMVP | Ticktin Robert | General Counsel & COO | A | Employee Stock Option (right to buy) | 319270 | $0.00 | 319,270.0000 | 53,211,507 | 9999.99% | 0.60% |
| July 1, 2025 | PMV Pharmaceuticals, Inc. | $PMVP | Ticktin Robert | General Counsel & COO | S | Common Stock | 23151 | $1.06 | 98,695.0000 | 51,933,604 | 19.00% | 0.04% |